Cargando…

Off-label Drug Prescription Pattern and Related Adverse Drug Reactions in the Medical Intensive Care Unit

Introduction: The utilization of prescription drugs as off-label is common. While this practice can be beneficial to some patients, it can raise a safety concern when scientific evidence is lacking; hence, this study was conducted to evaluate the off-label drug consumption and its adverse drug react...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raut, Asawari, Krishna, Kavita, Adake, Utkarsha, Sharma, Apurva A, Thomas, Anitta, Shah, Jignesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559754/ https://www.ncbi.nlm.nih.gov/pubmed/34733026 http://dx.doi.org/10.5005/jp-journals-10071-23909

Ejemplares similares

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)

Patterns and predictors of off-label prescription of psychiatric drugs
por: Vijay, Aishwarya, et al.
Publicado: (2018)

Prescription pattern & adverse drug reactions of prokinetics
por: Biswas, Mansij, et al.
Publicado: (2019)

Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit
por: Vieira, Verônica Cheles, et al.
Publicado: (2021)

Off-label prescriptions in intensive care unit: the Chinese experience
por: Liu, Lin, et al.
Publicado: (2018)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
por: Simsek, Melek, et al.
Publicado: (2019)

Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice
por: Egberts, Karin M., et al.
Publicado: (2022)

Drug labeling: The study of compliance of regulatory requirements for prescription drugs in India
por: Shah, Suchi, et al.
Publicado: (2020)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

Adverse Drug Reactions in the Intensive Care Unit
por: Moore, Philip, et al.
Publicado: (2017)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals – a nationwide study
por: Kimland, E, et al.
Publicado: (2012)

Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany
por: Lücke, Caroline, et al.
Publicado: (2018)

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
por: Fairman, Kathleen A., et al.
Publicado: (2010)

Multiple drugs: Livedoid reaction and off-label use: case report
Publicado: (2020)

Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
por: dos Santos, Laura Goedel, et al.
Publicado: (2023)

Cardiac adverse reactions with off-label Covid-19 treatments
Publicado: (2020)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil
por: Gonçalves, Marcele Giacomin, et al.
Publicado: (2016)

Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care – a nationwide study
por: Olsson, J, et al.
Publicado: (2011)

Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS Versus the U.S. Justice Department
por: Curtiss, Frederic R.
Publicado: (2009)

Incidence of unlicensed and off-label prescription in children
por: Langerová, Petra, et al.
Publicado: (2014)

Off-label drugs for weight management
por: Hendricks, Ed J
Publicado: (2017)

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
por: Wu, Leihong, et al.
Publicado: (2019)

Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels
por: Tiftikci, Mert, et al.
Publicado: (2019)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

Adverse drug reactions and off-label and unlicensed medicines in children: a nested case?control study of inpatients in a pediatric hospital
por: Bellis, Jennifer R, et al.
Publicado: (2013)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
por: Aamir, Muhammad, et al.
Publicado: (2018)

A dataset of 200 structured product labels annotated for adverse drug reactions
por: Demner-Fushman, Dina, et al.
Publicado: (2018)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

A tale of two drugs: Off and on-label
por: Narayanan, Raja, et al.
Publicado: (2017)

Profiling off-label prescriptions in cancer treatment using social health networks
por: Nikfarjam, Azadeh, et al.
Publicado: (2019)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2015)

Multiple drugs: Various reactions, lack of efficacy and off-label use: 2 case reports
Publicado: (2022)

Textbook of adverse drug reactions /
Publicado: (1977)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_80pefmcl5p91j64d9ed8k5m8p2